Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Statement

12 Apr 2022 07:00

RNS Number : 0315I
Electrocomponents PLC
12 April 2022
 

12 April 2022, 7.00am

 

Electrocomponents plc today issues a trading update for the year ended 31 March 2022, ahead of publishing full-year results on 24 May 2022

 

Like-for-like revenue growth1

Region

Q1 toJun 2021

Q2 toSep 2021

Q3 toDec 2021

Q4 toMar 2022

Year to Mar 2022

EMEA

37%

22%

14%

19%

22%

Americas

40%

35%

37%

33%

36%

Asia Pacific

31%

31%

25%

23%

27%

Group

37%

26%

21%

23%

26%

 

 

Group like-for-like revenue growth for the year ended 31 March 2022 was 26%. Please refer to our commentary accompanying the recent trading update released on 9 March 2022 for more detail. As reported on 30 March 2022, we expect our full year adjusted operating profit margin to be at the top end of the consensus range2. Due to our trading update on 9 March 2022 and Investor Event on 30 March 2022, there will be no conference call taking place today. Webcasts from both are on our website www.electrocomponents.com/investors/financial-results.

 

As previously announced, in early May Electrocomponents plc will become RS Group plc as we strengthen our position as one brand, united behind our single purpose of 'making amazing happen for a better world'. An announcement will be made when the name change becomes effective with a revised stock TIDM (ticker). Until such an announcement is made, trading will continue under the existing ticker 'ECM'. No action is required on the part of any shareholder.

 

 

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Tulchan Communications

020 7353 4200

 

Notes:

1. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions and the effects of changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2020/21 is converted at 2021/22 average exchange rates for the period.  

2. Consensus for the year ended 31 March 2022 (as reported on 30 March 2022) of adjusted profit before tax of £306.0 million within a range of £299.9 million to £313.0 million (source: Electrocomponents.com/investors/analyst-coverage).

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2022 for euro and US dollar were €1.176 and $1.366 respectively. Every 1 cent movement in the euro has a c. £1.8 million impact on annual adjusted profit before tax. Every 1 cent movement in the US dollar has a c. £0.7 million impact on annual adjusted profit before tax.  

4. We expect to see a negative impact of around £7 million on revenue from fewer trading days in 2022/23 compared to 2021/22.  

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFEDSIILLIF
Date   Source Headline
7th Mar 20173:43 pmRNSDirector Declaration
1st Mar 201712:28 pmRNSTotal Voting Rights
15th Feb 20172:48 pmRNSDirector/PDMR Shareholding
10th Feb 20177:00 amRNSTrading update
1st Feb 20172:15 pmRNSHolding(s) in Company
1st Feb 201710:37 amRNSBlock listing Interim Review
31st Jan 201710:33 amRNSTotal Voting Rights
23rd Jan 201711:59 amRNSHolding(s) in Company
13th Jan 20174:01 pmRNSNotice of trading update
3rd Jan 201711:41 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDirectorate Change
9th Dec 201610:28 amRNSHolding(s) in Company
1st Dec 201611:12 amRNSTotal Voting Rights
18th Nov 20167:00 amRNS2017 Half-year Financial Results
14th Nov 201612:37 pmRNSHolding(s) in Company
31st Oct 20161:37 pmRNSTotal Voting Rights
7th Oct 20163:47 pmRNSHolding(s) in Company
4th Oct 20161:25 pmRNSHolding(s) in Company
30th Sep 201610:12 amRNSTotal Voting Rights
15th Sep 20162:48 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSTrading Statement
12th Sep 20167:00 amRNSDirectorate Change
1st Sep 201610:19 amRNSTotal Voting Rights
1st Aug 20169:42 amRNSBlock listing Interim Review
29th Jul 20162:50 pmRNSDirector/PDMR Shareholding
29th Jul 201611:35 amRNSTotal Voting Rights
22nd Jul 20169:23 amRNSDirector/PDMR Shareholding
20th Jul 201612:43 pmRNSResult of AGM
20th Jul 20167:00 amRNSDirectorate Change
20th Jul 20167:00 amRNSTrading Statement
5th Jul 201612:06 pmRNSNotice of Trading Update
30th Jun 201611:28 amRNSTotal Voting Rights
27th Jun 201611:39 amRNSDirector/PDMR Shareholding
23rd Jun 20161:04 pmRNSDirector/PDMR Shareholding
20th Jun 201610:40 amRNSDirector/PDMR Shareholding
16th Jun 20169:44 amRNSAnnual Financial Report
31st May 201610:45 amRNSTotal Voting Rights
23rd May 201610:40 amRNSHolding(s) in Company
19th May 20167:00 amRNSFinal Results
29th Apr 201610:00 amRNSTotal Voting Rights
5th Apr 20167:00 amRNSTrading Update
1st Apr 20167:00 amRNSTotal Voting Rights
31st Mar 20167:00 amRNSDirectorate Change
29th Mar 201611:34 amRNSHolding(s) in Company
18th Mar 201612:03 pmRNSDirector/PDMR Shareholding
18th Mar 20169:53 amRNSNotice of trading update
14th Mar 201611:37 amRNSDirector/PDMR Shareholding
1st Mar 20169:22 amRNSTotal Voting Rights
10th Feb 20167:00 amRNSTrading Statement
1st Feb 201610:41 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.